South32 (ASX:S32) share price rises amid coal mine decision appeal

The South32 Ltd (ASX: S32) share price edged higher today after the company lodged an appeal to expand one of its coal mines in NSW.

| More on:
Mining worker making frame with his hands and peering through it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The South32 Ltd (ASX: S32) share price edged higher today. The company was in focus after news filtered through it has lodged an appeal against the New South Wales Independent Planning Commission (IPC) over its decision to block an extension of South 32's Dendrobium coal mine.

By the market's close, shares in the metals and mining company were trading at $2.99 – up 0.34%. Similarly , the S&P/ASX 200 Index (ASX: XJO) is 0.2% higher.

Let's take a closer look at today's developments.

Case background

Back in February, the IPC blocked a decision by the state Department of Planning to approve South32's $956 million plan to extend the life of the Dendrobium coal mine to 2048 and extract an additional 78 million tonnes of coal from the site.

The commission cited the high likelihood of adverse impacts on the local environment. The commission stated it felt South32 could not manage the risk appropriately and any damage would be irreversible. It went on to say the benefits of the project did not outweigh these costs.

"[T]he level of risk posed by the Project has not been properly quantified and based on the potential for long-term and irreversible impacts — particularly on the integrity of a vital drinking water source for the Macarthur and Illawarra regions, the Wollondilly Shire and Metropolitan Sydney — it is not in the public interest," the IPC's Statement of Reasons for Decision read.

Conservative NSW politicians at the time, including Deputy Premier John Barilaro and Upper House MP and One Nation leader Mark Latham, decried the decision.

"The decision by the IPC to reject South 32's Dendrobium coal expansion will be recorded as one of the most destructive decisions since the IPC's formation," Mr Barilaro said at a press conference soon after the decision was handed down.

South32 appeal

In a statement yesterday, South32 said it would appeal the decision.

"South32 has commenced proceedings in the Land and Environment Court of New South Wales, seeking a judicial review of the Independent Planning Commission's (IPC) assessment of the Dendrobium Mine Extension Project," a spokesperson for the company said.

"This is one of a number of options we are pursuing in relation to the project, and we continue to work with all relevant stakeholders and look at potential alternative mine plans."

"We have a long history of operating safely and responsibly in the Illawarra region and the proposed Dendrobium Mine Extension would provide major economic and social benefits for the Illawarra region and for New South Wales," the spokesperson added.

The news was also reported by mainstream outlets such as the Australian Broadcasting Corporation (ABC) and The Australian

The ABC is also reporting that one of the other options South32 is pursuing includes direct lobbying of the state government.

South32 share price snapshot

Over the past 12 months, the South32 share price has increased by around 60%. The company recently announced its results for the quarter, which also sent its share price higher.

South32 has a market capitalisation of around $14.2 billion.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Three people gather around a large computer screen where they are looking at something that is captivating their interest with a graphic image of data and digital technology material superimposed to the right hand third of the image.
Share Market News

Here's how the ASX 200 market sectors stacked up last week

ASX tech shares led the market for a third consecutive week with a 4.63% increase.

Read more »

Mini house on a laptop.
Dividend Investing

Do ASX 200 dividend shares out-earn Aussie property?

We compare the forecast FY25 dividend yields of the top 10 ASX 200 companies to rental property yields.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Best Shares

Top ASX shares to buy with $500 in November 2024

$500 worth of ASX shares might not sound like a huge investment. But, to realise the benefits of compounding, you…

Read more »

A diverse group of people form a circle at a park and raise their arms together.
Share Market News

Here are the top 10 ASX 200 shares today

ASX investors ended the trading week on a high note this Friday...

Read more »

Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Catapult, De Grey Mining, Domino's, and Nufarm shares are charging higher

These shares are ending the week strongly. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »